Telix Pharmaceuticals Limited

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Telix Pharmaceuticals Limited
Ownership
Public
Status
Active
Headquarters country
Australia
Ticker symbol
TLX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002007191

Board of directors

Follow this board

Chief executives

Christian Behrenbruch · MD & Group CEO
Since March 2026

Board connections

3 of this board's directors also sit on 5 other boards.

Network of Telix Pharmaceuticals Limited's board connections Anika Therapeutics Inc. Anika Therapeutics Inc... Avient Corporation Avient Corporation Evolus Inc. Evolus Inc. Medtronic plc. Medtronic plc. The Cooper Companies Inc. The Cooper Companies I... David N. Gill David N. Gill Maria Rivas Maria Rivas William R. Jellison William R. Jellison Telix Pharmaceuticals Limi...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$996,738
2 purchases by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Apr 29, 2026 Christian Behrenbruch Director, Officer (MD & Group CEO) Open-market purchase +33,435 $14.87 $497,178
Apr 28, 2026 Christian Behrenbruch Director, Officer (MD & Group CEO) Open-market purchase +34,500 $14.48 $499,560
Mar 29, 2026 Smith Darren Charlton Officer (Group Chief Financial Officer) Option exercise +1,111 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.